RCHY1 and cancer: Even though little research has been done on specific proteins like p53, Mdm2, and Pirh2, a deeper understanding of the protein-protein interaction network offers crucial insights into putative druggable hot spots, facilitating the development of novel modulators for therapeutic interventions against cancer (Daver et al., 2023).